Senate Bill 666, the 2025 Water Safety Act, is a broad PFAS response measure. It creates a PFAS Mitigation Fund within the Department of Environmental Quality to provide grants to local governments operating public water and wastewater systems for PFAS sampling and monitoring, treatment technology upgrades, and emergency response or remediation of contamination. The bill also directs the North Carolina Collaboratory to receive recurring state funding for PFAS research on detection, environmental fate and transport, remediation technologies, and public health impacts.
The bill establishes state maximum contaminant levels for several PFAS compounds in drinking water, including PFOA, PFOS, PFNA, GenX (HFPO-DA), PFHxS, PFBS, and certain PFAS mixtures. It requires the Commission for Public Health to adopt a compliance schedule for public water systems that is substantially identical to the federal schedule in EPA rules. In addition, it directs DEQ, in consultation with the Collaboratory, to develop PFAS concentration limits and source-reduction or treatment requirements for certain direct dischargers and significant industrial users, with enforceable permit conditions and a compliance schedule of up to 36 months.
The bill would change state law by adding a new PFAS mitigation part to Chapter 130A, amending the State Water Infrastructure Authority’s duties, and creating new drinking water standards and discharge-control requirements. It appropriates $56 million recurring to the PFAS Mitigation Fund and $14 million recurring to the Collaboratory for the 2025-2026 fiscal year, making the measure both a regulatory and funding package. Affected parties include local water and wastewater systems, industrial dischargers, publicly owned treatment works, the Department of Environmental Quality, the Commission for Public Health, and the UNC Collaboratory.
Because no committee transcripts or votes were provided, there is no recorded debate or voting history to gauge formal sentiment. Based on the bill’s structure, the general posture appears strongly pro-regulation and pro-remediation, with an emphasis on public health protection, scientific research, and assistance to local systems facing contamination. The bill also includes a limited exemption for regulated entities that can show PFAS levels are below background or not contributing to downstream exceedances, suggesting an attempt to balance enforcement with site-specific evidence.
The main points of potential contention are likely to be the cost of the recurring appropriations, the feasibility and timing of the new drinking water and discharge limits, and the burden on industrial users and POTWs required to monitor, treat, or reduce PFAS discharges. Another likely issue is the scope of state authority and rulemaking, since the bill directs agencies to adopt temporary and permanent rules and to implement standards that may exceed or track federal requirements. Supporters would likely emphasize contamination cleanup, public health, and long-term infrastructure investment, while opponents may focus on compliance costs, technical uncertainty, and implementation challenges.
The bill would add new statutory authority for PFAS mitigation grants, create a dedicated PFAS Mitigation Fund, and expand the duties of the State Water Infrastructure Authority to award grants for PFAS-related contamination response. It would also establish state drinking water maximum contaminant levels for several PFAS compounds and require rulemaking for compliance schedules. For dischargers, the bill would require DEQ and the Environmental Management Commission to develop and implement PFAS concentration limits, monitoring, pretreatment, and permit conditions for certain significant industrial users and direct dischargers, affecting NPDES and pretreatment permitting statewide.
No committee discussion or vote record was provided, so there is no documented legislative sentiment from hearings or floor action. The bill’s text reflects a strong policy preference for aggressive PFAS regulation, remediation funding, and scientific research, indicating a generally protective public-health orientation. At the same time, the inclusion of compliance schedules and narrow exemptions suggests awareness of implementation and cost concerns.
The likely areas of contention are the bill’s recurring fiscal commitments, the practicality of meeting very low PFAS limits, and the regulatory burden on local utilities and industrial facilities. Industrial users and wastewater systems may object to new pretreatment, monitoring, and source-reduction requirements, while environmental and public health advocates are likely to support the bill’s stricter standards and grant funding. The balance between state-set standards and federal alignment, as well as the agencies’ broad rulemaking authority, may also be debated.